The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) in Brazil has discovered a way to transform hydroxyapatite, a bioceramic ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.

A personal look at six weeks using Mounjaro — from expectations and side effects to the unexpected mental shift around food, appetite, and daily habits. Honest thoughts on what changed, what didn’t, ...

The approval was granted 54 days after the request for review was approved, the agency said in a statement. The new dosage will be available in April at pharmacies in the U.S., with a price to be ...

Rendering a drug effective or ineffective in a flash at the appropriate location—this is the focus of research in photopharmacology. The goal is to develop drugs that can be switched on and off with ...

Muscle mass increased or remained stable relative to body weight in middle-aged mice and humans on GLP-1 drugs.

Pythons eat huge meals after monthslong fasts. Researchers identified molecules that skyrocket in their blood after a meal. One caused obese mice to eat less and lose weight, similar to semaglutide.

Psychedelic drug MDMA may help people manage PTSD symptoms. But it should only be used in certain contexts, according to two ...

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...